Navigation Links
Supplement use predicts folate status in Canadian women
Date:4/10/2012

Ottawa, Ontario (April 10, 2012) Researchers have gained new insight into why 22% of Canadian women of childbearing age are still not achieving a folate concentration considered optimal for reducing the risk of having babies with neural tube defects, despite a virtual absence of folate deficiency in the general Canadian population.

When the authors examined a nation-wide study, they found a main reason why some women are not achieving levels optimal for reducing risk is many do not take the supplemental folic acid recommended for this population.

This article appears in the April issue of the journal Applied Physiology, Nutrition, and Metabolism.

"This segment of the population is the target of fortification and supplementation policies and clarifying the factors associated with achieving optimal folate status is essential to refining interventions," Cynthia Colapinto, lead author. "The importance of folic acid supplementation for women of childbearing age must be distinguished from the needs of the general population."

The study found folic acid supplement intake was the most significant predictor of optimal RBC (red blood cell) folate concentration for this subgroup. Supplement intake, in turn, was significantly related to income, with a greater percentage of folic acid supplement users in the highest income group. Furthermore, only 25% of Canadian women of childbearing age reported taking a folic acid supplement. According to the report, these data indicate a need for targeted strategies to improve compliance with folic acid supplement recommendations to assist women of childbearing age in achieving desired folate concentrations.


'/>"/>

Contact: Judy Letourneau
judy.letourneau@nrcresearchpress.com
Canadian Science Publishing (NRC Research Press)
Source:Eurekalert

Page: 1

Related biology news :

1. Soy-based S-equol supplement reduces metabolic syndrome risk factors
2. Vitamin B and omega-3 supplementation and cancer: New data
3. ChromaDex® Expands National Launch of its BluScience™ Line of Dietary Supplements Through McKesson
4. L-arginine: Supplement tested on fit, athletic men shows no advantage
5. Obese adolescents benefit from high-dose vitamin D supplements
6. Health benefits of broccoli require the whole food, not supplements
7. Glucosamine-like supplement suppresses multiple sclerosis attacks
8. Popular herbal supplements may adversely affect chemotherapy treatment
9. BD Biosciences Introduces Chemically Defined Cell Culture Media Supplement that Increases Biopharmaceutical Protein Production
10. Vitamin D supplements found to be safe for healthy pregnant women
11. U of I study: Before you start bone-building meds, try dietary calcium and supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017 The report "Gesture Recognition and Touchless Sensing Market ... - Global Forecast to 2022", published by MarketsandMarkets, the market is expected to ... between 2017 and 2022. Continue Reading ... ... ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... FRANCISCO and MOUNTAIN VIEW, Calif. ... , "Eating Well Made Simple," and 23andMe , ... help guide better food choices.  Zipongo can now provide ... their food preferences, health goals and biometrics, but also ... certain food choices. Zipongo,s personalized food decision ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
(Date:3/23/2017)... YORK , March 23, 2017 ... ... of death, putting significant strain on health care systems, in ... cancer diagnoses rises, so too does the development of innovative ... minimum side effects. Among the many types of cancer treatments, ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a ... Biobank and GSK to generate genetic sequence data from the ... will enable researchers to gain valuable insights to support advances ... of serious and life threatening diseases. ... Genetic evidence has revolutionized ...
(Date:3/22/2017)... 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that Dr. Miriam Kidron ... presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing ... Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
Breaking Biology Technology: